BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29632473)

  • 1. Endothelial Monocyte-Activating Polypeptide-II Induces BNIP3-Mediated Mitophagy to Enhance Temozolomide Cytotoxicity of Glioma Stem Cells via Down-Regulating MiR-24-3p.
    Zhang J; Liu L; Xue Y; Ma Y; Liu X; Li Z; Li Z; Liu Y
    Front Mol Neurosci; 2018; 11():92. PubMed ID: 29632473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway.
    Zhou W; Liu L; Xue Y; Zheng J; Liu X; Ma J; Li Z; Liu Y
    Front Mol Neurosci; 2017; 10():68. PubMed ID: 28348518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Endothelial-Monocyte-Activating Polypeptide-II Induced Autophagy by Down-Regulating miR-20a in U-87 and U-251 Glioma Cells.
    Chen J; Liu L; Liu Y; Liu X; Qu C; Meng F; Ma J; Lin Y; Xue Y
    Front Cell Neurosci; 2016; 10():128. PubMed ID: 27242439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest.
    Yu Q; Liu L; Wang P; Yao Y; Xue Y; Liu Y
    Cell Cycle; 2017 Jun; 16(11):1085-1092. PubMed ID: 28436750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO3a protects glioma cells against temozolomide-induced DNA double strand breaks via promotion of BNIP3-mediated mitophagy.
    He C; Lu S; Wang XZ; Wang CC; Wang L; Liang SP; Luo TF; Wang ZC; Piao MH; Chi GF; Ge PF
    Acta Pharmacol Sin; 2021 Aug; 42(8):1324-1337. PubMed ID: 33879840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy Induction by Endothelial-Monocyte Activating Polypeptide II Contributes to the Inhibition of Malignant Biological Behaviors by the Combination of EMAP II with Rapamycin in Human Glioblastoma.
    Ma J; Meng F; Li S; Liu L; Zhao L; Liu Y; Hu Y; Li Z; Yao Y; Xi Z; Teng H; Xue Y
    Front Mol Neurosci; 2015; 8():74. PubMed ID: 26648842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of miR-330-3p/PKC-α Signaling Pathway in Low-Dose Endothelial-Monocyte Activating Polypeptide-II Increasing the Permeability of Blood-Tumor Barrier.
    Liu J; Liu L; Chao S; Liu Y; Liu X; Zheng J; Chen J; Gong W; Teng H; Li Z; Wang P; Xue Y
    Front Cell Neurosci; 2017; 11():358. PubMed ID: 29311822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial-Monocyte Activating Polypeptide II Suppresses the
    Li Z; Ma J; Liu L; Liu X; Wang P; Liu Y; Li Z; Zheng J; Chen J; Tao W; Xue Y
    Front Mol Neurosci; 2017; 10():208. PubMed ID: 28701921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
    Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
    Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5.
    Chen L; Xue Y; Zheng J; Liu X; Liu J; Chen J; Li Z; Xi Z; Teng H; Wang P; Liu L; Liu Y
    Front Mol Neurosci; 2018; 11():35. PubMed ID: 29467620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of miRNA signature associated with BMP2 and chemosensitivity of TMZ in glioblastoma stem-like cells.
    Guo X; Luo Z; Xia T; Wu L; Shi Y; Li Y
    Genes Dis; 2020 Sep; 7(3):424-439. PubMed ID: 32884997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
    Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
    Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
    Ma S; Fu T; Zhao S; Gao M
    Eur J Pharmacol; 2019 Jun; 852():42-50. PubMed ID: 30851271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2/E1B-19KD-Interacting Protein 3/Light Chain 3 Interaction Induces Mitophagy in Spinal Cord Injury in Rats Both In Vivo and In Vitro.
    Yu D; Li M; Nie P; Ni B; Zhang Z; Zhou Y
    J Neurotrauma; 2018 Sep; 35(18):2183-2194. PubMed ID: 29566574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2.
    Zhang X; Yu J; Zhao C; Ren H; Yuan Z; Zhang B; Zhuang J; Wang J; Feng B
    Biomed Pharmacother; 2019 Jan; 109():2192-2202. PubMed ID: 30551476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein.
    Zhitao J; Long L; Jia L; Yunchao B; Anhua W
    Tumour Biol; 2015 Dec; 36(12):9621-30. PubMed ID: 26142735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial-monocyte-activating polypeptide II induces rat C6 glioma cell apoptosis via the mitochondrial pathway.
    Liu LB; Xie H; Xue YX; Liu YH; Li Z; Wang P
    Biochem Biophys Res Commun; 2015 Feb; 457(4):595-601. PubMed ID: 25600803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells.
    Yu Z; Zhao G; Li P; Li Y; Zhou G; Chen Y; Xie G
    Oncol Lett; 2016 Apr; 11(4):2792-2800. PubMed ID: 27073554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma.
    Gao XY; Zang J; Zheng MH; Zhang YF; Yue KY; Cao XL; Cao Y; Li XX; Han H; Jiang XF; Liang L
    Front Cell Dev Biol; 2021; 9():620883. PubMed ID: 33614649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.